Resonate Blends, Inc. (KOAN)
APOLLO BioWellness Inc. focuses its efforts on researching, formulating, and bringing to market products designed for human health within the regenerative medicine sector. A significant part of its operations involves the commercialization of licensed, naturally derived compounds currently awaiting patent approval, which are specifically engineered to boost an individual's innate capacity to mobilize adult stem cells from their own bone marrow. Additionally, the firm possesses the marketing rights for an all-natural, two-pronged dietary supplement crafted to help regulate hunger by engaging the body's intrinsic signaling pathways between the brain and the digestive system. Beyond its current offerings, the company is also deeply involved in research and development initiatives. These efforts are dedicated to exploring new frontiers, such as Secretogues aimed at enhancing a person's endogenous growth hormone synthesis, along with other natural bioactive formulations intended to optimize human physiological performance. This is achieved by harnessing the body's own biological mechanisms, entirely without the use of pharmaceutical drugs. The company maintains its corporate headquarters in North Bergen, New Jersey.
Sector: Services-Prepackaged Software
Industry: Drug Manufacturers - Specialty & Generic
Resonate Blends, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 195.25M shares outstanding
USAPOLLO BioWellness Inc. focuses its efforts on researching, formulating, and bringing to market products designed for human health within the regenerative medicine sector. A significant part of its operations involves the commercialization of licensed, naturally derived compounds currently awaiting patent approval, which are specifically engineered to boost an individual's innate capacity to mobilize adult stem cells from their own bone marrow.
Additionally, the firm possesses the marketing rights for an all-natural, two-pronged dietary supplement crafted to help regulate hunger by engaging the body's intrinsic signaling pathways between the brain and the digestive system. Beyond its current offerings, the company is also deeply involved in research and development initiatives. These efforts are dedicated to exploring new frontiers, such as Secretogues aimed at enhancing a person's endogenous growth hormone synthesis, along with other natural bioactive formulations intended to optimize human physiological performance. This is achieved by harnessing the body's own biological mechanisms, entirely without the use of pharmaceutical drugs.
The company maintains its corporate headquarters in North Bergen, New Jersey.
Leadership
I. Sigmund Mosley, Jr.
Chair, Compensation Committee
John M. Sterling
Director Nominee
John N. Spencer, Jr.
Chair, Audit Committee
Judith A. Vitale
Director Nominee
Employees
6
Country
US
Sector
Healthcare
Website
apollobiowellness.com
based on 195.25M shares outstanding
US30d Avg
6.72M
60d Avg
5.66M
90d Avg
5.69M